Sponsor:
CARGO Therapeutics
Code:
NCT05972720
Conditions
Cancer
Relapsed/Refractory Large B-cell Lymphoma (LBCL)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Fludarabine (Conditional therapy)
Cyclophosphamide Monohydrate (Conditional therapy)
firi-cel (Experimental drug)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations